Company profileListed on Tehran Stock Exchange

Tamin Pharmaceutical Investment Company

Tamin Pharmaceutical Investment Company (TPICO) is a Tehran-based, Tehran Stock Exchange-listed pharmaceutical investment holding. Its portfolio spans medicine manufacturing, active pharmaceutical ingredients, distribution, medical products and related healthcare businesses in Iran. The company matters as a listed gateway to pharmaceutical supply-chain exposure, domestic medicine demand and sector-level corporate partnerships.

ListingListed on Tehran Stock Exchange
ExportMedium
VerificationBasic
ConfidenceHigh
Updated20/07/2026
OPERATING PROFILE

Operations & footprint

Products and services

Tamin Pharmaceutical Investment Company is a pharmaceutical investment holding with exposure to drug manufacturing, active pharmaceutical ingredients, distribution, medical and healthcare-related products, and sector-level portfolio management. Its activity connects capital allocation, healthcare demand, pharmaceutical supply chains, regulated medicine markets, import-dependent inputs, and listed healthcare-sector exposure.

Operations and assets

A portfolio of pharmaceutical and healthcare-related companies, including businesses involved in drug production, active pharmaceutical ingredients, distribution and medical products.

Geographic footprint

Headquartered in Tehran, Iran.

Investor Lens

Commercial and investment relevance

In the Hormuz investment graph, Tamin Pharmaceutical Investment Company connects healthcare demand, listed capital, pharmaceutical manufacturing, raw-material access, distribution networks, and supply-shortage risk. It is useful for screening pharma-sector concentration, mapping subsidiary exposure, evaluating import-dependence pressure, and identifying where regulated pricing, domestic production, and medicine availability intersect. Foreign-facing analysis should verify current portfolio composition, subsidiary operations, disclosure data, procurement dependencies, sanctions exposure, compliance rules, and counterparty quality before commercial use. TPICO is a relevant counterpart for buyers, suppliers and partners seeking exposure to Iran’s pharmaceutical ecosystem. Its portfolio model connects manufacturers and input suppliers with pharmaceutical distribution and healthcare demand.

DECISION RISKS

Constraints, risk & compliance

Key risks and constraints

Portfolio performance is exposed to the availability and cost of pharmaceutical inputs, operational performance at portfolio companies, and pricing conditions in Iran’s regulated medicine market.

LOCAL COMPANY ACCESS

Need more than a public profile?

Ask Hormuz to investigate, verify or act locally around Tamin Pharmaceutical Investment Company. Tell us exactly what you need.

Contact the companyVerify local presenceArrange a site visitRequest pricingCheck capacitySpeak with salesConfirm specific informationCover an exhibition
Open a Desk request No service is preselected.
Related context

Connected Intelligence

Relevant geography, industry, market and execution context for this profile.

Common questions

Frequently asked questions

Direct answers to the questions most likely to arise when reviewing this profile.

What is Tamin Pharmaceutical Investment Company?

Tamin Pharmaceutical Investment Company, known as TPICO, is a listed pharmaceutical investment holding headquartered in Tehran, Iran.

What sectors does TPICO cover?

Its portfolio covers pharmaceutical manufacturing, active pharmaceutical ingredients, pharmaceutical distribution, medical products and related healthcare businesses.

Where does TPICO operate?

TPICO is headquartered in Tehran and operates through pharmaceutical and healthcare-related portfolio businesses in Iran.